Palisade Bio, Inc. (PALI)
NASDAQ·Healthcare·Biotechnology
$1.97
+0.26%
Mkt Cap $328.15M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 23, 2026 | — | — | — | -$0.02 | -$0.04 | -100.00% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$0.32 | -$0.38 | -18.75% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.48 | -$0.58 | -20.83% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$0.84 | -$0.47 | +44.05% | — | — |
| Q1 2025 Mar 24, 2025 | — | $4.00K | — | -$1.99 | -$0.69 | +65.33% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$3.35 | -$2.32 | +30.75% | — | — |
| Q3 2024 Aug 12, 2024 | — | — | — | -$2.93 | -$3.32 | -13.31% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$4.80 | -$4.59 | +4.38% | — | — |
| Q1 2024 Mar 26, 2024 | — | -$250.00K | — | -$5.17 | -$3.75 | +27.47% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.39 | -$7.35 | -1784.62% | — | — |
| Q3 2023 Aug 11, 2023 | — | — | — | -$0.45 | -$7.95 | -1666.67% | — | — |
| Q2 2023 May 12, 2023 | — | $250.00K | — | -$0.72 | -$8.10 | -1025.00% | — | — |
| Q1 2023 Mar 22, 2023 | — | — | — | -$2.43 | $6.47 | +366.26% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$4.00 | -$59.97 | -1399.25% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$8.50 | -$89.96 | -958.35% | — | — |
| Q2 2022 May 13, 2022 | — | — | — | -$210.00 | -$194.90 | +7.19% | — | — |
| Q1 2022 Mar 16, 2022 | — | — | — | -$11.75 | $554.72 | +4821.02% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$18.00 | -$224.89 | -1149.39% | — | — |
| Q3 2021 Aug 24, 2021 | — | — | — | — | -$3073.46 | — | — | — |
| Q2 2021 May 14, 2021 | — | — | — | — | -$16.98 | — | — | — |